Diabetes in the elderly and in women: Cardiovascular risks

Cardiology Clinics

Volumn 22, Issue 4, 2004, Pages 541-551

  Sowers, James R ^a,b  

^a University of Missouri   (United States)

^b Veterans Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; RAMIPRIL;

AGING; BLOOD PRESSURE REGULATION; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY RISK; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIET; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOOD INTAKE; GLUCOSE INTOLERANCE; HEALTH CARE COST; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LABORATORY TEST; LIFESTYLE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PATIENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SMOKING CESSATION; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 6344248981     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2004.06.008     Document Type: Review

References (110)

1. J.R. Sowers, and S. Haffner Treatment of cardiovascular and renal risk factors in the diabetic hypertensive Hypertension 40 2002 781 788
2. J.R. Sowers Diabetes mellitus and cardiovascular disease in women Arch Intern Med 158 1998 617 621
3. A.H. Mokdad, E.S. Ford, B.A. Bowman, N.E. Nelson, M.M. Engelgau, and F. Vinicor Diabetes trends in the US: 1990-98 Diabetes Care 23 2000 1278 1283
4. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutritional Examination Survey JAMA 287 3 2002 356 359
5. S.I. McFarlane, M. Banerji, and J.R. Sowers Insulin resistance and cardiovascular disease J Clin Endocrinol Metab 86 2001 713 718
6. J.P. Boyle, A.A. Honeycutt, K.M. Narajan, T.J. Hoerger, L.S. Geiss, and H. Chen Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US Diabetes Care 24 2001 1936 1940
7. Screening for type 2 diabetes mellitus in adults: recommendations and rationale Ann Int Med 138 2003 212 214
8. N.K. Fukagawa, L.G. Bandini, and J.B. Young Effect of age on body composition and resting metabolic rate Am J Physiol 259 1990 E233 E238
9. R.J. Troisi, J.W. Heinrold, P.S. Vokonas, and S.T. Weiss Cigarette smoking, dietary intake, and physical activity: effects on body fat distribution: the Normative Aging Study Am J Clin Nutr 53 1991 1104 1111
10. W.M. Kohrt, K.A. Obert, and J.O. Holloszy Exercise training improves fat distribution patterns in 60- to 70-year-old men and women J Gerontol 47 1992 M99 M105
11. E.T. Poelman, M.J. Toth, L.B. Bunyard, A.W. Gardner, K.E. Donaldson, and E. Coleman Physiological predictions of increasing total and central adiposity in aging men and women Arch Intern Med 155 1995 2443 2448
12. J. Stevens, J. Cai, E.R. Pamuk, D.F. Williamson, M.J. Thun, and J.L. Wood The effect of age on the association between body mass index and mortality N Engl J Med 338 1998 1 7
13. J.R. Sowers Obesity and cardiovascular disease Clin Chem 44 B 1998 1821 1825
14. R.R. Wing, K.A. Matthews, L.H. Kuller, E.N. Meilahn, and P. Plantinga Waist to hip ratio in middle-aged women: associations with behavioral and psychological factors and with changes in cardiovascular risk factors Arterioscler Thromb 11 1991 1250 1257
15. A.R. Folsom, S.A. Kay, T.A. Sellers, C.P. Hong, J.R. Cerhan, and J.D. Potter Body fat distribution and 5-year risk of death in older women JAMA 269 1993 483 487
16. R.S. Schwartz, W.P. Shuman, V. Larson, K.C. Cain, G.W. Fellingham, and J.C. Beard The effect of intensive endurance exercise training on body fat distribution in young and older men Metabolism 40 1991 545 551
17. D.L. Wingard, P. Sinsheimer, E.L. Barrett-Connor, and J.B. McPhillips Community-based study of prevalence of NIDDM in older adults Diabetes Care 13 1990 3 8
18. W.B. Kannel Risk factors for cardiovascular disease in women Cardiol Rev 18 3 2001 11 15
19. A. Gastaldelli, Y. Meryazaki, M. Pettite, M. Matsuda, S. Mahankali, and E. Santini Metaboblic effects of visceral fat accumulation in type 2 diabetes J Clin Endocrinol Metab 87 11 2002 5098 5103
20. M. Brochu, R.D. Starling, A. Tchernof, D.E. Matthews, E. Garcia-Rubi, and E.T. Poehlman Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women J Clin Endocrinol Metab 85 2000 2378 2384
21. H.M. Lakka, T.A. Lakka, J. Tuomilehto, and J.I. Salonen Abdominal obesity is associated with increased risk of acute coronary events in men Eur Heart J 23 2002 706 713
22. A. Festa, R. D'Agostino, L. Mykannen, R.P. Tracy, and S.M. Haffner Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 2000 42 47
23. P. Bjorntorp Metabolic differences between visceral fat and subcutaneous abdominal fat Diabetic Metab 26 Suppl 3 2000 10 12
24. J. Janke, S. Engeli, K. Gorzelniak, F.C. Luft, and A.M. Sharma Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors Diabetes 51 6 2002 1699 1707
25. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat Med 7 2001 947 953
26. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, and R.E. Pratley Hypoadiponectinemia in obesity and type 2 diabetes J Clin Endocrinol Metab 86 2001 1930 1935
27. W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, and C.L. Chao Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin J Clin Endocrinol Metab 86 2001 3815 3819
28. N. Kubota, Y. Terauchi, T. Yamarichi, T. Kubota, M. Moroi, and J. Matsui Disruption of adiponectin causes insulin resistance and neointimal formation J Biol Chem 277 2002 25836 25866
29. T. Tsunckawa, T. Hayashe, Y. Suzuki, H. Matsui-Hirai, H. Kano, and A. Fukatsu Plasma adiponectin plays an important role in improving insulin resistance with ghmyperide in elderly type 2 diabetic subjects Diabetes Care 26 2 2003 285 296
30. A.R. Shuldiner, R. Yang, and D.W. Gong Resistin, obesity and insulin resistance - the emerging role of the adipocyte as an endocrine organ N Engl J Med 345 2001 1345 1346
31. J.X. Ma, J.H. Warram, A. Trishitta, and A. Doria Genetic variants at the resistant locus and the risk of type 2 diabetes in Caucasians J Clin Endocrinol Metab 87 2002 4407 4410
32. U.N. Das Is obesity an inflammatory condition? Nutrition 17 2001 953 956
33. A.E. Hak, D.A. Coen, and M. Stehower Associations of C-reactive protein with measures of obesity, insulin resistance and subclinical atherosclerosis in healthy, middle-aged women Arteriosclerosis Thromb Vasc Biol 19 1999 1986 1991
34. G.S. Hotamialigil Mechanisms of TNF-a-induced insulin resistance Exp Clin Endocrinol Diabetes 107 1999 119 125
35. M. Visser, L.M. Bonter, G.M. McQuillan, M.H. Wener, and T.B. Harris Elevated c-reactive protein levels in overweight and obese adults JAMA 282 1999 2131 2138
36. E.S. Ford Body mass index, diabetes and C-reactive protein among US adults Diabetes Care 22 1999 1971 1977
37. A.D. Pradhan, J.E. Manson, and N. Rifai C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
38. I. Juhan-Vague, M.C. Alessi, and P.E. Morange Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity Ann Med 32 Suppl 1 2000 78 84
39. P.A. Sakkinen, P. Wahl, M. Cushman, M.R. Lewis, and R.P. Tracy Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome Am J Epidemiol 152 2000 897 907
40. I. Mertens, M. Van der Planken, B. Corthouts, M. Wauters, F. Peiffer, and I. De Leeuw Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women Horm Metab Res 33 2001 602 607
41. A. Festa, R. D'Agostinio Jr., R.P. Tracy, and S.M. Haffner Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type diabetes: the Insulin Resistance Atherosclerosis Study Diabetes 51 2002 1131 1137
42. D.J. Schneider, and B.E. Sobel Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor 1: implications for vascular disease in hyperinsulinemic states Proc Natl Acad Sci USA 88 1991 9959 9963
43. Y.Z. Chen, M. Su, R. Walia, Q. Hao, and D.E. Vaughan Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promotor by glucose in vascular smooth muscle cells J Biol Chem 273 1998 8225 8231
44. N. Brown, K.S. Kim, Y.O. Chen, L.S. Blevins, J.H. Nadeau, and S.G. Meranze Synergistic effect of a adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production J Clin Endocrinol Metab 85 2000 336 349
45. C.R. Carvalho, S.L. Brenelli, A.C. Silva, A.L. Nunes, L.A. Velloso, and M.J. Saad Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats Endocrinology 137 1996 151 159
46. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J Clin Invest 106 2000 473 481
47. J.R. Sowers, M. Epstein, and E.D. Frohlich Diabetes, hypertension, and cardiovascular disease: an update Hypertension 37 2001 1053 1059
48. J.R. Sowers, M. Williams, M. Epstein, and G. Bakris Hypertension in patients with diabetes. Strategies for drug therapy to reduce complications Postgrad Med 107 2000 47 54
49. T.W. Gress, F.J. Nieto, E. Shahar, M.R. Wofford, and F.L. Brancati Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study N Engl J Med 342 2000 905 912
50. J.R. Sowers, and G.L. Bakris Antihypertensive therapy and the risk of type 2 diabetes mellitus N Engl J Med 342 2000 969 970
51. D. Rothenbacher, A. Hoffmeister, H. Brenner, and W. Koenig Physical activity, coronary heart disease, and inflammatory response Arch Intern Med 163 2003 1200 1205
52. S. Kurl, J.A. Laukkan, R. Rauramaa, T.A. Lakka, J. Sivenius, and J.T. Salonen Cardiorespiratory fitness and the risk of stroke in men Arch Intern Med 163 2003 1682 1688
53. J. Stamler, O. Vaccaro, J.D. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
54. G. Asman, P. Cullen, and H. Schulte Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study Core 105 2002 310 315
55. J.D. Curb, S.L. Pressel, J.A. Cutler, P.J. Savage, W.B. Appergate, and H. Black Effect of diuretic-based antihypertensive treatment on cardiovascular risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group JAMA 276 1996 1886 1892
56. Tight blood pressure control and risk of macrovascular and microvascular complications in type 3 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 317 1998 703 713
57. L. Hansson, A. Zanchetti, S.G. Carruthers, B. Dahlof, D. Elmfeldt, and S. Julius Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group Lancet 351 1998 1755 1762
58. J. Tuomilehto, D. Rastenyte, W.H. Birkenhager, L. Thijs, R. Antikainen, and C.J. Bulpitt Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators N Engl J Med 340 1999 677 684
59. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators Lancet 355 2000 253 259
60. L.H. Lindholm, H. Ibsen, B. Dahlof, R.B. Devereux, S.E. Kjeldsen, and G. Beevers Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol Lancet 359 2002 995 1003
61. Major outcomes in high-risk hypertensive patients randomized to angiotgensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 23 2002 2981 2997
62. L.B. Goldstein, R. Adams, K. Becker, C.D. Furberg, P.B. Gorelick, and G. Hodemenos Primary prevention of ischemic stroke: a statement for healthcare professionals from the stroke council of the American Heart Association Circulation 103 2001 163 182
63. B. Stigmayr, and K. Asplund Diabetes as a risk factor for stroke: a population perspective Diabetologia 38 1995 1061 1068
64. N.J. Marrish, L.K. Stevens, J.H. Fuller, R.J. Jarrett, and H. Keen Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the SHO Multinational Study of Vascular Disease in Diabetes Diabetologia 34 1991 590 594
65. C.M. Burchfiel, J.D. Curb, B.L. Rodriguez, R.D. Abbott, D. Chiu, and K. Yano Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Stroke 25 1994 951 957
66. H. Miettinen, S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjects Stroke 27 1996 2033 2039
67. R.D. Abbott, R.P. Donahue, S.W. MacMahon, D.M. Reed, and K. Yano Diabetes and the risk factors for stroke: The Honolulu Heart Program JAMA 257 1987 949 952
68. J.P. Torjry, L.K. Niskanen, E.A. Lansimier, K.P. Partanen, and M.I. Uusitupa Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus 27 1996 1316 1318
69. J. Tuomilehto, and D. Rastenyte Diabetes and glucose intolerance as risk factors for stroke J Cardiovasc Risk 6 1999 241 249
70. R.L. Sacco Reducing the risk of stroke in diabetes: what have we learned that is new? Diabetes Obes Metab 4 Suppl 1 2002 527 534
71. T.C. Fagan, and J.R. Sowers Greater cardiovascular risks and greater benefits of therapy Arch Intern Med 159 10 1999 1033 1034
72. C. Berger, and I.M. Hakim The association of hyperglycemia with cerebral edema in stroke Stroke 17 1986 865 871
73. C.S. Gray, R. Taylor, F.M. French, K.G. Alberti, G.S. Venables, and O.F. James The prognostic value of stress hyperglycemia and previously unrecognized diabetes in acute stroke Diabet Med 4 1987 237 240
74. American Diabetes Association Position statement: treatment of hypertension in adults with diabetes Diabetes Care 25 2002 S71 S73
75. G.L. Bakris, M. Williams, L. Dworkin, W.J. Elliott, M. Epstein, and R. Toto Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Am J Kidney Dis 36 2000 646 661
76. J.R. Sowers, and S.L. Farrow Treatment of elderly hypertensive patients with diabetes, renal disease and coronary heart disease Am J Geriatr Cardiol 5 1996 57 70
77. United States Renal Data System Annual data report: atlas of end-stage renal disease in the United States: incidence and prevalence of ESRD Am J Kidney Dis 36 2000 S37 S54
78. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
79. Diabetic Nephropathy American Diabetes Association Diabetes Care 25 Suppl 1 2002 S85 S89
80. M. Ruddy Angiotensin II receptor blockade in diabetic nephropathy Am J Hypertens 15 2002 466 467
81. S. Agewall, J. Wikstrand, S. Ljungman, and B. Fagerberg Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group Am J Cardiol 80 1997 164 169
82. S.F. Dinneen, and H.C. Gerstein The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systemic overview of the literature Arch Intern Med 157 1997 1413 1418
83. J.R. Sowers, and M.A. Lester Diabetes and cardiovascular disease Diabetes Care 22 Suppl 3 1999 C14 C20
84. R. Bigazzi, S. Bianchi, D. Baldari, and V.M. Campese Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension J Hypertens 16 1998 1325 1333
85. A. Jager, P.J. Kostense, H.G. Ruhe, R.J. Heine, G. Nijpels, and J.M. Dekker Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study Arterioscler Thromb Vasc Biol 19 1999 617 624
86. H.C. Gerstein, J.F. Mann, J. Pogue, S.F. Dinneen, J.P. Halle, and B. Hoogwerf Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE study Investigators Diabetes Care 23 Suppl 2 2000 B35 B39
87. F.M. Sacks, L.P. Svetkey, V.M. Vollmer, L.J. Appel, G.A. Bray, and D. Harsha Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group N Engl J Med 344 1 2001 3 10
88. E. Obarzanek, F.M. Sacks, W.M. Vollmer, G.A. Bray, E.R. Miller III, and P.H. Lin DASH Research Group. Effects on blood lipids of a blood pressure lowering diet. The Dietary Approaches to Stop Hypertension (DASH) Trial Am J Clin Nutr 74 1 2001 80 89
89. S.I. McFarlane, S.J. Jacober, N. Winer, J. Kaur, J.P. Castro, and M.A. Wui Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers Diabetes Care 25 2002 718 723
90. MRC/BHF Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial Lancet 360 2002 7 22
91. L.L. Humphrey, B.K.S. Chan, and H.C. Sox Postmenopausal replacement therapy and the primary prevention of cardiovascular disease Ann Intern Med 137 2002 273 284
92. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results, Humana Press, 2002.
93. J.R. Kaseta, and J.R. Sowers Diabetes mellitus and cardiovascular disease in the older woman Clin Geriatrics 7 10 1999 52 62
94. E. Barrett-Conner, B.A. Cohn, D. Windgard, and S. Edelstein Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265 1991 627 631
95. R.J. Goldberg, M. Larson, and D. Levy Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study Arch Intern Med 156 1996 505 506
96. S. Oparil, R.L. Levin, and Y.F. Chen Sex hormones and the vasculature J.R. Sowers Endocrinology of the vasculature 1996 Humana Press Totowa (NJ) 225 238
97. C. Albert Sex differences in cardiac arrest survivors Circulation 93 1996 1170 1176
98. C.S. May Insulin-independent diabetes mellitus mortality: the risk of cigarette smoking Circulation 82 1990 37 43
99. D.R. Holdright Risk factors for cardiovascular disease in women J Hum Hypertens 12 1998 667 673
100. Y. Liao, R.S. Cooper, G.A. Mensah, and D.L. McGee Left ventricular hypertrophy has a greater impact on women than in men Circulation 92 1995 805 810
101. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
102. J.D. Neaton, R.H. Grimm Jr., R.J. Prineas, J. Stamler, G.A. Grandits, and P.J. Elmer (Treatment of Mild Hypertension Study Research Group). Treatment of Mild Hypertension Study: Final results JAMA 270 1993 713 724
103. J. Murragat, J. Sala, R. Masia, M. Pavesi, G. Sanz, and V. Valle Mortality differences between men and women following myocardial infarction JAMA 280 1998 1405 1409
104. A.A. Furomate-Dawson, D.K. Pandey, W. Elliot, C.F. de Leon Mendes, A.J. Al-Hani, and S. Hollenberg Hypertension in women: the women take heart project Am J Hypertens 5 2003 38 46
105. E.J. Giltay, J. Lambert, and L.J. Gooren Sex steroids, insulin and arterial stiffness in women and men Hypertens 34 1999 590 597
106. M.S. Fernandez-Alfonso, and C. Gonzalez Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems J Hypertens 17 1999 1355 1361
107. D.F. Skafar, R. Xu, J. Morales, J. Ram, and J.R. Sowers Female sex hormones and cardiovascular disease in women J Clin Endocrin Metab 82 12 1998 3913 3928
108. A.M. Kaneya, D. Grady, and E. Barrett-Connor Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus Arch Intern Med 162 2002 1737 1745
109. S. Natarajan, Y. Liao, and G. Cao Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease Arch Intern Med 163 2003 1735 1740
110. J.R. Sowers Diabetes mellitus and cardiovascular disease in women Arch Intern Med 158 1997 617 621